Kairos Ventures is a venture capital firm investing in scientific discoveries and commercializing them into viable businesses.
Phone: 310-271-1866
9440 S. Santa Monica Blvd
Suite 710
Beverly Hills, 90210
California, United States
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2021-01-27 | Stoichea | Seed VC | $5M | Craig Mundie, David Walt, Hugh Evans, J. Todd Mitchell, Joe Allison, Louis Simpson, and Wally Loewenbaum |
2021-01-17 | Royale Finance | Seed VC | $1.45M | Alphabit Fund, AU21, Fomocraft Ventures, and Vendetta Capital |
2021-01-14 | Novosteo | Series A | $5.5M | BioCrossroads, Elevate Ventures, Purdue Research Foundation, and Undisclosed Investors |
2020-12-22 | Provivi | Series C - II | $45.5M | Lanx Capital, Pontifax AgTech, Spruce Capital Partners, Temasek, Tybourne Capital Management, and Vivo Capital |
2020-12-10 | Actuate Therapeutics | Series B - III | $14.48M | Bios Partners |